|
|
|
Insider
Information: |
Cuss Francis M |
Relationship: |
Director |
City: |
Princeton |
State: |
NJ |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
331,905 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$12,957,246 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
331,905 |
|
|
Total
Value |
$12,957,246 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Bristol-Myers Squibb Co |
BMY |
EVP & CSO |
2017-03-10 |
321,905 |
|
0 |
Premium* |
|
Rubius Therapeutics, Inc. |
RUBY |
Director |
2018-07-20 |
10,000 |
2018-07-20 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BMY |
Bristol-Myers Squibb Co |
SVP Research, R&D |
|
2011-05-01 |
4 |
D |
$28.10 |
$34,732 |
D/D |
(1,236) |
95,872 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
SVP Research |
|
2012-03-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,702 |
99,574 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
SVP Research |
|
2012-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
1,003 |
100,577 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
SVP Research |
|
2012-03-01 |
4 |
D |
$32.64 |
$55,847 |
D/D |
(1,711) |
98,866 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
SVP Research |
|
2012-03-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,130 |
102,996 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
SVP Research |
|
2012-03-02 |
4 |
D |
$32.59 |
$64,626 |
D/D |
(1,983) |
102,337 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
SVP Research |
|
2012-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
1,324 |
104,320 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
SVP Research |
|
2012-03-03 |
4 |
D |
$32.59 |
$44,485 |
D/D |
(1,365) |
104,725 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
SVP Research |
|
2012-03-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,753 |
106,090 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
SVP Research |
|
2012-03-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,039 |
107,764 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
SVP Research |
|
2012-03-04 |
4 |
D |
$32.59 |
$36,012 |
D/D |
(1,105) |
106,659 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
SVP Research |
|
2012-03-06 |
4 |
D |
$32.33 |
$224,079 |
D/D |
(6,931) |
117,594 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
SVP Research |
|
2012-03-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
17,866 |
124,525 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
SVP Research |
|
2012-08-30 |
4 |
S |
$32.89 |
$3,887,269 |
D/D |
(118,190) |
147,022 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
SVP Research |
|
2012-08-30 |
4 |
OE |
$17.51 |
$3,010,191 |
D/D |
147,618 |
265,212 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
SVP Research |
|
2012-11-02 |
4 |
D |
$33.18 |
$102,559 |
D/D |
(3,091) |
150,599 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
SVP Research |
|
2012-11-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,668 |
153,690 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
SVP Research |
|
2013-03-03 |
4 |
D |
$37.15 |
$51,750 |
D/D |
(1,393) |
152,958 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
SVP Research |
|
2013-03-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,753 |
154,351 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
SVP Research |
|
2013-03-07 |
4 |
A |
$0.00 |
$0 |
D/D |
4,086 |
202,061 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
SVP Research |
|
2013-03-07 |
4 |
D |
$37.53 |
$830,877 |
D/D |
(22,139) |
179,922 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
SVP Research |
|
2013-03-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
45,017 |
197,975 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
SVP Research |
|
2013-03-13 |
4 |
OE |
$17.51 |
$2,021,810 |
D/D |
84,952 |
264,874 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
SVP Research |
|
2013-03-13 |
4 |
S |
$38.47 |
$2,681,859 |
D/D |
(69,713) |
195,161 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
SVP Dscvry & Exp Clinl ResrchO |
|
2010-05-04 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
69,985 |
|
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|